/ Print /

Health Management

Innovative strategies help fight multiple myeloma: What every exec should knowAs new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.
Are non-opioid therapies more desirable than opioids for chronic pain?A new study from researchers from the Minneapolis VA Health Care System has interesting findings.
Five imitation-worthy palliative care programsHere's how five health plans are successfully approaching palliative care.
Diabetes prevention programs avert, delay disease onsetDiabetes accounts for one out of every 10 American healthcare dollars spent, but new national programs are helping address this issue.
Patients who need PCSK9 inhibitors cant get themStudy: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.
Here’s why preventive care should be a priorityA Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.
How one hospital reduced pediatric epilepsy emergency visits, admissionsNationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project.
Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.
Partnership aims to make insulin more affordableCVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.
Regulatory changes for community oncology: What health execs should knowOne thing that is unlikely to change under the new Administration is the goal of reducing the cost of healthcare through various alternative payment initiatives. Here’s how that will affect oncology.